Literature DB >> 3930950

Comparative properties of monoclonal antibodies comprising a high-affinity anti-fluorescyl idiotype family.

R M Bates, D W Ballard, E W Voss.   

Abstract

The T-dependent BALB/c murine immune response to fluorescein (F1) is characterized by structural heterogeneity at the protein level exemplified in part by a significantly wide range of affinities (Ka), and apparent lack of dominant idiotypes. In order to generate an idiotype family, xenogenic anti-idiotype (anti-ID) antibodies raised against anti-F1 monoclonal antibody (MCA) 4-4 (Ka = 1.7 X 10(10) M-1) were used in a solid-phase radioimmunoassay (SPRIA) to screen 68 anti-F1 hybridomas generated from multiple cell fusions for idiotypically related immunoglobulins. Four affinity-purified MCAs (designated 9-40, 10-25, 5-14 and 5-27) bearing 4-4 idiotypic determinants (ID 4-4) exhibited discrete isoelectric focusing spectrotypes (pI range = 6.8-7.7), significantly different fluorescence quenching values (38-95%) of bound ligand, binding affinities ranging from 3.3 X 10(7) to 5.3 X 10(8) M-1, similar active site inaccessibility to iodide, and closely related fine-specificity patterns for fluorescyl analogues. Idiotypic relatedness of each MCA to prototype 4-4 was quantitated by SPRIA, the results demonstrating that: each 125I-labeled MCA bound significantly to solid-phase anti-ID 4-4, and the concns of heterologous MCAs 9-40, 10-25 and 5-14 required for 50% inhibition of 125I-4-4/anti-ID 4-4 binding were comparable to homologous Ig protein. The finding that ID 4-4 bearing anti-F1 MCAs exhibit various binding properties and affinities is consistent with variable-region somatic diversification in anti-F1 affinity maturation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930950     DOI: 10.1016/0161-5890(85)90072-0

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  How well can an idiotope peptide mimic replace its parent idiotype in a synthetic peptide vaccine?

Authors:  James S Cavenaugh; Hsu-kun Wang; Jiang Sha; Corey Hansen; Kongnara Papangkorn; Richard S Smith; James N Herron
Journal:  Pharm Res       Date:  2004-08       Impact factor: 4.200

2.  Characterization of a single-chain T-cell receptor expressed in Escherichia coli.

Authors:  W F Hoo; M J Lacy; L K Denzin; E W Voss; K D Hardman; D M Kranz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

3.  Lupus-derived autoantibodies with dual autoactivity: anti-DNA and anti-Fc. II. Fine specificity of anti-self autoreactivity.

Authors:  C A Rumbley; E W Voss
Journal:  Clin Exp Immunol       Date:  1995-11       Impact factor: 4.330

4.  Fluorescence measurements of immune complexes of Mab 4-4-20 with isomeric haptens.

Authors:  C A Swindlehurst; E W Voss
Journal:  Biophys J       Date:  1991-03       Impact factor: 4.033

5.  Quenching of fluorescein-conjugated lipids by antibodies. Quantitative recognition and binding of lipid-bound haptens in biomembrane models, formation of two-dimensional protein domains and molecular dynamics simulations.

Authors:  M Ahlers; D W Grainger; J N Herron; K Lim; H Ringsdorf; C Salesse
Journal:  Biophys J       Date:  1992-09       Impact factor: 4.033

6.  Isolation of high affinity human antibodies directly from large synthetic repertoires.

Authors:  A D Griffiths; S C Williams; O Hartley; I M Tomlinson; P Waterhouse; W L Crosby; R E Kontermann; P T Jones; N M Low; T J Allison
Journal:  EMBO J       Date:  1994-07-15       Impact factor: 11.598

7.  Inhibition or activation of human T cell receptor transfectants is controlled by defined, soluble antigen arrays.

Authors:  D E Symer; R Z Dintzis; D J Diamond; H M Dintzis
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.